SKY92 measures the activity of 92 genes in the malignant myeloma plasma cells to quantify how aggressive a myeloma is while FISH looks for gene changes in cells per the Second Revised International ...

Multiple myeloma is a type of cancer characterized by the uncontrolled proliferation of clonal plasma cells, which leads to ...

Myeloma involves malignant plasma cells that build up in the bone marrow or the soft tissue in the center of bones. The term malignant describes the tendency to progressively worsen, invade ...

Multiple myeloma is a relatively uncommon cancer of plasma cells, where excessive proliferation of these malignant cells within the bone marrow leads to abnormal antibody production. The disease ...

Myeloma proteins were characterized for heavy ... observed in the immune response appear to be secondary to the malignant process and often approach normality during remission.

Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes. In recent years, CAR-T cell therapies have ...

Multiple myeloma (MM) is a malignant plasma cell disorder accounting for approximately 10% of all hematologic malignancies. The overall prognosis is driven by tumor biology but other factors such ...

Researchers have discovered and analysed a rare but serious side effect of an innovative form of blood cancer therapy. Some forms of blood cancer, such as multiple myeloma and lymphoma, are ...

SkylineDx has published a new study marking a “significant advancement” in the understanding and identification of high-risk (HR) multiple myeloma (MM) patients. The Dutch company’s ...